BioSymetrics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $6.06M

BioSymetrics General Information

Description

Developer of a biomedical artificial intelligence platform designed to provide disease understanding and personalized drugs. The company's platform performs predictive analytics on research and healthcare data used in pharmaceutical research, and accelerates early-stage drug discovery, enabling biopharmaceutical researchers, hospitals, and health systems to build a comprehensive view of human health.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 315 Main Street, 2nd floor
  • Huntington
  • New York, NY 11743
  • United States
Primary Industry
Decision/Risk Analysis
Other Industries
Drug Delivery
Parent Company
Corporate Office
  • 315 Main Street, 2nd floor
  • Huntington
  • New York, NY 11743
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioSymetrics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 08-Apr-2025 $6.06M Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Secondary Transaction - Private Completed Generating Revenue
3. Seed Round 04-Aug-2021 Completed Generating Revenue
2. Accelerator/Incubator 11-Sep-2018 $3.85M $3.85M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
To view BioSymetrics’s complete valuation and funding history, request access »

BioSymetrics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
To view BioSymetrics’s complete cap table history, request access »

BioSymetrics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biomedical artificial intelligence platform designed to provide disease understanding and personalized dr
Decision/Risk Analysis
New York, NY
13 As of 2025

Lexington, MA
 

Hong Kong, Hong Kong
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioSymetrics Competitors (6)

One of BioSymetrics’s 6 competitors is Valo, a Venture Capital-Backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Valo Venture Capital-Backed Lexington, MA
InSilico Medicine Cayman Formerly VC-backed Hong Kong, Hong Kong
insitro Venture Capital-Backed South San Francisco, CA
BenevolentAI Formerly PE-Backed Luxembourg, Luxembourg
Exscientia Formerly VC-backed Oxford, United Kingdom
To view BioSymetrics’s complete competitors history, request access »

BioSymetrics Patents

BioSymetrics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240161001-A1 Data processing pipeline and platform for zebrafish phenotyping Pending 15-Nov-2022
US-20250182848-A1 Methods, systems, and frameworks for gene disease prioritization in drug discovery Pending 15-Nov-2022
US-12369861-B2 Methods, systems, and frameworks for debiasing data in drug discovery predictions Active 03-Jun-2022
US-20230389878-A1 Methods, systems, and frameworks for debiasing data in drug discovery predictions Active 03-Jun-2022
US-11379757-B2 Methods, systems, and frameworks for data analytics using machine learning Active 31-Jul-2019 G16H50/70
To view BioSymetrics’s complete patent history, request access »

BioSymetrics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioSymetrics Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
AI Venture Labs Accelerator/Incubator Minority
AJI Capital Venture Capital Minority
Dasein Capital Venture Capital Minority
Mogility Capital Venture Capital Minority
NVIDIA GPU Ventures Corporate Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

BioSymetrics FAQs

  • When was BioSymetrics founded?

    BioSymetrics was founded in 2017.

  • Where is BioSymetrics headquartered?

    BioSymetrics is headquartered in New York, NY.

  • What is the size of BioSymetrics?

    BioSymetrics has 13 total employees.

  • What industry is BioSymetrics in?

    BioSymetrics’s primary industry is Decision/Risk Analysis.

  • Is BioSymetrics a private or public company?

    BioSymetrics is a Private company.

  • What is the current valuation of BioSymetrics?

    The current valuation of BioSymetrics is .

  • What is BioSymetrics’s current revenue?

    The current revenue for BioSymetrics is .

  • How much funding has BioSymetrics raised over time?

    BioSymetrics has raised $6.58M.

  • Who are BioSymetrics’s investors?

    AI Venture Labs, AJI Capital, Dasein Capital, Mogility Capital, and NVIDIA GPU Ventures are 5 of 6 investors who have invested in BioSymetrics.

  • Who are BioSymetrics’s competitors?

    Valo, InSilico Medicine Cayman, insitro, BenevolentAI, and Exscientia are some of the 6 competitors of BioSymetrics.

  • When was BioSymetrics acquired?

    BioSymetrics was acquired on 08-Apr-2025.

  • Who acquired BioSymetrics?

    BioSymetrics was acquired by Lunai Bioworks.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process